vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and PRA GROUP INC (PRAA). Click either name above to swap in a different company.
PRA GROUP INC is the larger business by last-quarter revenue ($333.4M vs $208.9M, roughly 1.6× iRhythm Holdings, Inc.). PRA GROUP INC runs the higher net margin — 17.0% vs 2.7%, a 14.3% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 13.7%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $-90.4M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 14.2%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
PRA Group, Inc. is a publicly traded debt buyer and debt collection company based in Norfolk, Virginia. The company buys delinquent consumer debt from credit card issuers and other financial institutions at a discount and pursues collection of the full debt owed. Founded in 1996, PRA Group employs more than 3200 people in 18 countries.
IRTC vs PRAA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $333.4M |
| Net Profit | $5.6M | $56.5M |
| Gross Margin | 70.9% | — |
| Operating Margin | 1.1% | 37.7% |
| Net Margin | 2.7% | 17.0% |
| Revenue YoY | 27.1% | 13.7% |
| Net Profit YoY | 518.5% | 206.3% |
| EPS (diluted) | $0.18 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $333.4M | ||
| Q3 25 | $192.9M | $311.1M | ||
| Q2 25 | $186.7M | $287.7M | ||
| Q1 25 | $158.7M | $269.6M | ||
| Q4 24 | $164.3M | $293.2M | ||
| Q3 24 | $147.5M | $281.5M | ||
| Q2 24 | $148.0M | $284.2M | ||
| Q1 24 | $131.9M | $255.6M |
| Q4 25 | $5.6M | $56.5M | ||
| Q3 25 | $-5.2M | $-407.7M | ||
| Q2 25 | $-14.2M | $42.4M | ||
| Q1 25 | $-30.7M | $3.7M | ||
| Q4 24 | $-1.3M | $18.5M | ||
| Q3 24 | $-46.2M | $27.2M | ||
| Q2 24 | $-20.1M | $21.5M | ||
| Q1 24 | $-45.7M | $3.5M |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 68.8% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 68.8% | — | ||
| Q2 24 | 69.9% | — | ||
| Q1 24 | 66.3% | — |
| Q4 25 | 1.1% | 37.7% | ||
| Q3 25 | -4.4% | -101.4% | ||
| Q2 25 | -10.0% | 29.6% | ||
| Q1 25 | -20.5% | 27.7% | ||
| Q4 24 | -2.5% | 32.1% | ||
| Q3 24 | -34.1% | 32.0% | ||
| Q2 24 | -15.5% | 31.4% | ||
| Q1 24 | -28.9% | 26.0% |
| Q4 25 | 2.7% | 17.0% | ||
| Q3 25 | -2.7% | -131.0% | ||
| Q2 25 | -7.6% | 14.7% | ||
| Q1 25 | -19.3% | 1.4% | ||
| Q4 24 | -0.8% | 6.3% | ||
| Q3 24 | -31.3% | 9.6% | ||
| Q2 24 | -13.6% | 7.6% | ||
| Q1 24 | -34.6% | 1.4% |
| Q4 25 | $0.18 | $1.47 | ||
| Q3 25 | $-0.16 | $-10.43 | ||
| Q2 25 | $-0.44 | $1.08 | ||
| Q1 25 | $-0.97 | $0.09 | ||
| Q4 24 | $-0.03 | $0.47 | ||
| Q3 24 | $-1.48 | $0.69 | ||
| Q2 24 | $-0.65 | $0.54 | ||
| Q1 24 | $-1.47 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $104.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $979.9M |
| Total Assets | $1.0B | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $104.4M | ||
| Q3 25 | $565.2M | $107.5M | ||
| Q2 25 | $545.5M | $131.6M | ||
| Q1 25 | $520.6M | $128.7M | ||
| Q4 24 | $535.6M | $105.9M | ||
| Q3 24 | $522.0M | $141.1M | ||
| Q2 24 | $561.5M | $118.9M | ||
| Q1 24 | $569.1M | $108.1M |
| Q4 25 | $152.7M | $979.9M | ||
| Q3 25 | $121.9M | $928.5M | ||
| Q2 25 | $103.7M | $1.3B | ||
| Q1 25 | $86.7M | $1.2B | ||
| Q4 24 | $90.9M | $1.1B | ||
| Q3 24 | $71.8M | $1.2B | ||
| Q2 24 | $99.2M | $1.1B | ||
| Q1 24 | $90.3M | $1.1B |
| Q4 25 | $1.0B | $5.1B | ||
| Q3 25 | $995.2M | $5.0B | ||
| Q2 25 | $964.0M | $5.4B | ||
| Q1 25 | $926.1M | $5.1B | ||
| Q4 24 | $931.4M | $4.9B | ||
| Q3 24 | $909.7M | $4.9B | ||
| Q2 24 | $919.2M | $4.7B | ||
| Q1 24 | $909.8M | $4.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $-85.5M |
| Free Cash FlowOCF − Capex | $14.5M | $-90.4M |
| FCF MarginFCF / Revenue | 6.9% | -27.1% |
| Capex IntensityCapex / Revenue | 5.6% | 1.4% |
| Cash ConversionOCF / Net Profit | 4.70× | -1.51× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $-169.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $-85.5M | ||
| Q3 25 | $34.9M | $-10.1M | ||
| Q2 25 | $27.7M | $-12.9M | ||
| Q1 25 | $-7.9M | $-52.6M | ||
| Q4 24 | $19.2M | $-94.6M | ||
| Q3 24 | $24.3M | $-35.0M | ||
| Q2 24 | $11.8M | $-29.5M | ||
| Q1 24 | $-52.0M | $-73.0M |
| Q4 25 | $14.5M | $-90.4M | ||
| Q3 25 | $20.1M | $-11.3M | ||
| Q2 25 | $17.3M | $-14.2M | ||
| Q1 25 | $-17.3M | $-53.5M | ||
| Q4 24 | $12.4M | $-98.6M | ||
| Q3 24 | $15.5M | $-36.1M | ||
| Q2 24 | $3.4M | $-30.8M | ||
| Q1 24 | $-61.8M | $-73.5M |
| Q4 25 | 6.9% | -27.1% | ||
| Q3 25 | 10.4% | -3.6% | ||
| Q2 25 | 9.3% | -4.9% | ||
| Q1 25 | -10.9% | -19.8% | ||
| Q4 24 | 7.5% | -33.6% | ||
| Q3 24 | 10.5% | -12.8% | ||
| Q2 24 | 2.3% | -10.8% | ||
| Q1 24 | -46.8% | -28.8% |
| Q4 25 | 5.6% | 1.4% | ||
| Q3 25 | 7.7% | 0.4% | ||
| Q2 25 | 5.6% | 0.4% | ||
| Q1 25 | 5.9% | 0.3% | ||
| Q4 24 | 4.2% | 1.4% | ||
| Q3 24 | 6.0% | 0.4% | ||
| Q2 24 | 5.7% | 0.5% | ||
| Q1 24 | 7.4% | 0.2% |
| Q4 25 | 4.70× | -1.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.30× | ||
| Q1 25 | — | -14.37× | ||
| Q4 24 | — | -5.13× | ||
| Q3 24 | — | -1.29× | ||
| Q2 24 | — | -1.37× | ||
| Q1 24 | — | -21.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
PRAA
| GB | $170.1M | 51% |
| Other | $163.3M | 49% |
